These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35586986)

  • 21. An update on host immunity correlates and prospects of re-infection in COVID-19.
    Negi N; Maurya SP; Singh R; Das BK
    Int Rev Immunol; 2022; 41(4):367-392. PubMed ID: 34961403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal study on SARS-CoV-2 seroconversion, reinfection and neutralisation spanning several variant waves and vaccination campaigns, Heinsberg, Germany, April 2020 to November 2022.
    Schulte B; Richter E; Büning A; Baum M; Breuer A; Zorn J; König J; Geiger M; Eschbach-Bludau M; Heuser J; Zölzer D; Korencak M; Hollstein R; Beins E; Emmert D; Aldabbagh S; Eis-Hübinger AM; Streeck H
    Euro Surveill; 2024 Jun; 29(26):. PubMed ID: 38940003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 reinfection: the role of natural immunity, vaccines, and variants.
    Sciscent BY; Eisele CD; Ho L; King SD; Jain R; Golamari RR
    J Community Hosp Intern Med Perspect; 2021; 11(6):733-739. PubMed ID: 34804382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakthrough SARS-CoV-2 infections after vaccination: a critical review.
    Mohseni Afshar Z; Barary M; Hosseinzadeh R; Alijanpour A; Hosseinzadeh D; Ebrahimpour S; Nazary K; Sio TT; Sullman MJM; Carson-Chahhoud K; Babazadeh A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2051412. PubMed ID: 35302905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reinfection With SARS-CoV-2: Implications for Vaccines.
    Cohen JI; Burbelo PD
    Clin Infect Dis; 2021 Dec; 73(11):e4223-e4228. PubMed ID: 33338197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.
    Iversen K; Kristensen JH; Hasselbalch RB; Pries-Heje M; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Fischer TK; Juul Jensen CA; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Gybel-Brask M; Dessau RB; Sørensen E; Harritshøj L; Folke F; Sten C; Engel Møller ME; Benfield T; Ullum H; Jørgensen CS; Erikstrup C; Ostrowski SR; Nielsen SD; Bundgaard H
    Clin Microbiol Infect; 2022 May; 28(5):710-717. PubMed ID: 34543759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
    Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
    Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.
    Babiker A; Marvil CE; Waggoner JJ; Collins MH; Piantadosi A
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33361342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.
    Gütlin Y; Albertos Torres D; Gensch A; Schlotterbeck AK; Stöger L; Heller S; Infanti L; Barut GT; Thiel V; Leuzinger K; Hirsch HH; Buser A; Egli A
    Swiss Med Wkly; 2024 Jul; 154():3408. PubMed ID: 39137369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
    Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
    Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Reinfections Among Fully Vaccinated and Unvaccinated University Athletes-15 States, January-November 2021.
    Good MK; Czarnik M; Harmon KG; Aukerman D; O'Neal CS; Day C; Goerl K; Sifre K; Fink S; Riggs MA
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S236-S242. PubMed ID: 35771661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection.
    Maier HE; Kuan G; Saborio S; Carrillo FAB; Plazaola M; Barilla C; Sanchez N; Lopez R; Smith M; Kubale J; Ojeda S; Zuniga-Moya JC; Carlson B; Lopez B; Gajewski AM; Chowdhury M; Harris E; Balmaseda A; Gordon A
    Clin Infect Dis; 2022 Aug; 75(1):e257-e266. PubMed ID: 34411230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021-November 2021.
    Levin-Rector A; Firestein L; McGibbon E; Sell J; Lim S; Lee EH; Weiss D; Geevarughese A; Zucker JR; Greene SK
    Clin Infect Dis; 2023 Feb; 76(3):e469-e476. PubMed ID: 35594552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Kentucky, USA, 2020.
    Spicer KB; Glick C; Cavanaugh AM; Thoroughman D
    Int J Infect Dis; 2022 Jan; 114():21-28. PubMed ID: 34649001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland.
    Brown AC; Koshute PT; Cowley HP; Robinette MS; Gravelyn SR; Patel SV; Ju EY; Frommer CT; Zambidis AE; Schneider EJ; Zhao MY; Mugo BK; Clarke W; Kruczynski K; Pisanic N; Heaney CD; Colella TA
    Microbiol Spectr; 2023 Aug; 11(4):e0276522. PubMed ID: 37289070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
    Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.